A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/7024 (2006.01) A61K 31/702 (2006.01) A61K 31/715 (2006.01) A61P 9/00 (2006.01) A61P 9/10 (2006.01) C08B 37/00 (2006.01)
Patent
CA 2465776
The invention relates to the use of a dose of 2.5 mg of the pentasaccharide methyl O-(2-deoxy-2-sulfoamino-6-O-sulfo-.alpha.-D-glucopyranosyl)-(1-4)-O- (.beta.-D-glucopyranosyl uronic acid)-(1-4)-O-(2-deoxy-2-sulfoamino-3,6-di-O- sulfo-.alpha.-D-glucopyranosyl)-(1-4)-O-(2-O-sulfo-.alpha.-L-idopyranosyl uronic acid)-(1-4)-2-deoxy-2-sulfoamino-6-O-sulfo-.alpha.-D-glucopyranoside or a pharmaceutically acceptable salt thereof for the preparation of a medicament for the treatment of Acute Coronary Syndromes (ACS).
La présente invention concerne l'utilisation d'une dose de 2,5 mg de O-(2-deoxy-2-sulfoamino-6-O-sulfo-.alpha.-D-glucopyranosyl)-(1.fwdarw.4)-O-(acide .beta.-D-glucopyranosyl uronique)-(1.fwdarw.4)-O-(2-deoxy-2-sulfoamino-3,6-di-O-sulfo-.alpha.-D-glucopyranosyl)-(1.fwdarw.4)-O-(acide 2-O-sulfo-.alpha.-L-idopyranosyl uronique)-(1.fwdarw.4)-2-deoxy-2-sulfoamino-6-O-sulfo-.alpha.-D-glucopyranoside ou d'un sel de celui-ci, acceptable d'un point de vue pharmaceutique, pour préparer un médicament servant à traiter des syndromes coronariens aigus (Acute Coronary Syndromes : ACS).
Kirby Eades Gale Baker
Sanofi-Synthelabo
LandOfFree
Use of specific dose of fondaparinux sodium for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of specific dose of fondaparinux sodium for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of specific dose of fondaparinux sodium for the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1919188